Allergic diseases have reached epidemic proportions worldwide. An understanding of the
cellular and soluble mediators that are involved in allergic inflammatory responses not only …

… Polosa and colleagues followed up smokers for 24 months, after a 6-month period of
intervention during which ECs were given [Polosa et al. 2013a]. Only mild symptoms such as mouth …

There has been a recent increase in the prevalence of asthma worldwide; however, the 5–10%
of patients with severe disease account for a substantial proportion of the health costs. …

Background Electronic cigarettes (e-cigarettes) are becoming increasingly popular with
smokers worldwide. Users report buying them to help quit smoking, to reduce cigarette …

… A positive correlation (r 0.62 P 0.001) was observed when EGFR expression was analyzed
in relation to SBM thickening using Spearman’s test. Examination of the biopsies further …

Background Cigarette smoking is a tough addiction to break. Therefore, improved approaches
to smoking cessation are necessary. The electronic-cigarette (e-Cigarette), a battery-…

… 29 Farsalinos KE, Polosa R: Safety evaluation and risk assessment of electronic
cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Safety 2014;2:67–86. …

Cigarette smoking and asthma interact to induce important adverse effects on clinical,
prognostic and therapeutic outcomes. This review examines recent evidence on the harmful …

Background: The purpose of this study was to examine the prevalence and effects of current
smoking on adverse outcomes among hospitalized COVID-19 patients. Methods: A …

… Riccardo Polosa has received lecture fees and research funding from Pfizer and GlaxoSmithKline,
manufacturers of stop smoking medications. He has served as a consultant for Pfizer …